Your blood group determines whether you can catch severe COVID

The study, published in the journal PLOS Genetics, analyzed more than 3000 proteins to determine which are associated with the development of severe COVID-19. And, they identified six proteins that may contribute to severe COVID-19 infections and eight that may contribute to protection from severe COVID-19.

According to the study, a protein (ABO) that was identified as having a causal relationship with the risk of developing severe COVID-19 determines the blood groups, suggesting that the blood group may increase the risk of developing severe forms of the disease in people. play an important role in its development. ,

Study co-first author Alish Palmos, from King’s College London, said: “We have used a purely genetic approach to screen a large number of blood proteins and have established that a handful of patients with severe COVID-19 reasons for development.” “Honoring on this group of proteins is an important first step in the search for potentially valuable targets for the development of new therapies.”

What did the study reveal?

The analysis showed that an enzyme (ABO) that determines blood group was associated with both an increased risk of hospitalization and the need for respiratory support.

Researchers said this supports previous findings regarding a blood group with a higher probability of death.

Previous research showing that the proportion of group A is higher in COVID-19 positive individuals suggests that blood group A is a candidate for a follow-up study, he said.

Study co-author Christopher Hubel from King’s College London said: “The enzyme helps determine a person’s blood group and our study has linked this to both an increased risk of hospitalization and the need for respiratory support or death. “

(with inputs from agencies)